Zurich, Switzerland

Gary Jennings

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Unversität Zürich, Cytos Biotechnology Ag. Active years: 2006-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary Jennings. Retrieved from https://idiyas.com/inventor/gary-jennings-a1vdu9ol

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 18(Granted Patents)


Location History:

  • Zurich, CH (2006)
  • Zürich, CH (2020 - 2023)

Company Filing History:


Years Active: 2006-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gary Jennings: Innovator in Allergy Research

Introduction

Gary Jennings is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of allergy research, particularly focusing on cat allergies. With a total of 3 patents to his name, Jennings is dedicated to developing innovative solutions for allergy sufferers.

Latest Patents

Among his latest patents, Jennings has developed compositions aimed at reducing the allergenicity of cats. The first patent details a method that utilizes a composition to decrease the allergenicity of a cat for humans exposed to it. This invention includes compositions comprising a virus-like particle (VLP) and at least one Fel d1 protein. The compositions are designed to induce efficient immune responses, particularly antibody responses, in cats, making them useful for the treatment and prevention of cat allergies.

Career Highlights

Gary Jennings is affiliated with the Universität Zürich, where he conducts his research and development work. His innovative approach to allergy treatment has positioned him as a key figure in this specialized field.

Collaborations

Jennings has collaborated with notable colleagues such as Martin Bachmann and Thomas Kündig. Their combined expertise enhances the research and development of effective allergy treatments.

Conclusion

In summary, Gary Jennings is a pioneering inventor whose work in allergy research is making a significant impact. His innovative compositions for reducing cat allergenicity demonstrate his commitment to improving the lives of allergy sufferers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…